Zenflow, Inc., a pioneering medical technology company dedicated to transforming the treatment of benign prostatic hyperplasia (BPH), has successfully raised $24 million in funding. This significant investment underscores the urgent need for innovative solutions addressing the plight of the 40 million men in the United States and over 500 million globally who suffer from urinary obstruction related to BPH. Despite the availability of medications, many patients experience inadequate relief and are hesitant to pursue invasive surgical options that carry risks of troublesome side effects, including sexual dysfunction. In response to this pressing clinical demand, Zenflow has developed the groundbreaking Spring System, a revolutionary device designed to provide effective and lasting relief in a simple, atraumatic procedure that can be performed directly in a urologist's office. The funding will be pivotal in advancing clinical trials, scaling up production, and enhancing market outreach, allowing more patients to access this much-needed alternative to traditional treatments. With ongoing clinical trials yielding promising results extending up to four years post-treatment, Zenflow is poised to redefine the standard of care for men suffering from BPH. This funding not only highlights the confidence investors have in Zenflow's vision and technology but also signifies a commitment to improving the quality of life for millions facing debilitating urinary obstruction.
Revolutionizing BPH Treatment: Zenflow Raises $24 Million in Series C Funding
Get the full Zenflow, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Trackk
At Trackk, we're building a New-Gen trading platform. Designed for speed, precision, and simplicity. From faster trading to insightful analytics, we’re reimagining how the new generation connects with wealth and opportunities.
$3.7M Seed
today
Armada
Welcome to the new edge. Armada is the world’s first full-stack edge computing platform, revolutionizing connectivity, compute, and AI solutions where they’re needed most - anywhere on Earth.
$230.0M Series b
today
bunch
bunch is building the backbone of private markets with an end-to-end platform that enables funds and investors to operate, administer, and transact seamlessly. Designed with GPs at heart, bunch’s data-centric approach ensures GPs and LPs have access to accurate, up-to-date information in one centralized hub, fostering smarter, faster decision-making and transparent collaboration. Privacy Policy: https://www.bunch.capital/privacy-policy
$35.0M Series b
today
Gamehok
We aim to create a comprehensive platform tailored specifically for competitive gamers and streamers. Our goal is to assist gamers in their journey to become professional esports athletes by furnishing them with an optimal practice environment. Concurrently, our platform will empower gamers to cultivate their personal brand and foster a thriving community by facilitating connections and interactions with fellow gamers. Through our platform, we strive to support the growth and development of gamers, enabling them to hone their skills, establish their presence, and engage with a vibrant network of like-minded individuals within the competitive gaming sphere.
$100.0K Pre-seed
today
CRACI
CRACI is solving the upcoming EU Cyber Resilience Act. https://craci.com
$1.4M Pre-seed
today
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Rapido India | Series c | $18.0M | today |
| 2 |  Butterfly Medical Israel | Series c | $21.0M | 3d ago |
| 3 |  Yabie Sweden | Series c | $26.2M | 6d ago |
| 4 |  Trevi Therapeutics, Inc. United States | Series c | $50.5M | 6d ago |
| 5 |  Freyja Healthcare | Series c | $20.5M | 6d ago |